Total planned funding: $245,415,656
Clear active filters
Botswana
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Botswana | $245,415,656 |
Organizational Types
Own Agency | $60,572,001 |
NGO | $55,279,414 |
University | $53,212,221 |
Private Contractor | $30,977,966 |
Unknown | $27,398,467 |
Host Country Government Agency | $14,624,657 |
Other USG Agency | $2,049,930 |
Implementing Agency | $1,166,000 |
Multi-lateral Agency | $135,000 |
FBO | $0 |
Program Areas
Care | $77,204,552 |
Management and Operations | $43,554,095 |
Treatment | $37,608,324 |
Governance and Systems | $33,750,226 |
Prevention | $30,535,517 |
Testing | $22,762,942 |
Budget Codes
HVMS: Management and Operations | $43,554,095 |
HBHC: Care: Adult Care and Support | $35,744,420 |
HTXS: Treatment: Adult Treatment | $32,913,111 |
HVCT: Testing: HIV Testing and Counseling | $22,762,942 |
HVTB: Care: TB/HIV | $19,868,869 |
OHSS: Health Systems Strengthening | $17,680,761 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,330,664 |
HKID: Care: Orphans and Vulnerable Children | $17,050,343 |
HVSI: Strategic Information | $10,189,909 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,030,351 |
HLAB: Laboratory Infrastructure | $5,879,556 |
PDCS: Care: Pediatric Care and Support | $4,540,920 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,186,395 |
PDTX: Treatment: Pediatric Treatment | $2,400,035 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,301,094 |
HTXD: Treatment: ARV Drugs | $2,295,178 |
HMBL: Biomedical Prevention: Blood Safety | $571,832 |
HMIN: Biomedical Prevention: Injection Safety | $115,181 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
USG Aggregated Agencies:
$34,138,296
Countries/Regions
Not Available:
$27,398,467
Countries/Regions
University of Maryland:
$23,810,604
Countries/Regions
University of Washington:
$19,054,745
Countries/Regions